
Clinical Trials as Topic, Dose-Response Relationship, Drug, Anti-HIV Agents, HIV Infections, Drug Administration Schedule, Pyrrolidinones, Drug Resistance, Multiple, Viral, Raltegravir Potassium, HIV-1, Humans, Drug Therapy, Combination, HIV Integrase Inhibitors
Clinical Trials as Topic, Dose-Response Relationship, Drug, Anti-HIV Agents, HIV Infections, Drug Administration Schedule, Pyrrolidinones, Drug Resistance, Multiple, Viral, Raltegravir Potassium, HIV-1, Humans, Drug Therapy, Combination, HIV Integrase Inhibitors
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
